Lucid Group, Inc. (NASDAQ: LCID) shares are trading lower on Wednesday after the company announced its production and delivery numbers for the second quarter.</
Moderna Inc (NASDAQ: MRNA) and Merck & Co Inc (NYSE: MRK) announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neo
Penguin's OriginAI solution includes validated architectures backed by intelligent cluster management software and expert services that enable companies to rapidly deploy AI infrastructure at scalePenguin